SMARCA1 and cancer: A comprehensive understanding of chromatin remodelers that govern tissue stem cell fate determination, along with the consequences of their disruptions by using animal models, is imperative for developing effective therapeutic interventions to target chromatin remodelers, particularly the SWI/SNF complex, that are mutated in human cancers.